CK2-HTATSF1-TOPBP1信号轴调节瘤化疗反应
Qiushi Guo1, Jiao Zhao2, Yuan Li1
1Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, School of Basic Medical Sciences, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University, Tianjin, China.
在癌症中,CK2-HTATSF1-TOPBP1通路过度激活,从而降低化疗的有效性. 这种途径中的突变表明同源重组 (HR) 缺乏,使瘤易受特定的癌症药物影响.
科学领域:
- 分子生物学分子生物学
- 基因组学就是基因组学.
- 癌症研究 癌症研究
背景情况:
- 同源重组 (HR) 对基因组稳定性至关重要,并影响癌症治疗反应.
- 此前,CK2-HTATSF1-TOPBP1通路在HR中的作用及其在癌症中的临床意义尚不清楚.
研究的目的:
- 研究CK2-HTATSF1-TOPBP1通路对瘤发生和化疗反应的临床影响.
- 确定这种途径是否影响瘤HR状态和药物敏感性.
主要方法:
- 对多种癌症类型的基因表达和突变数据的分析.
- 在瘤样本中评估HR缺陷得分和药物脆弱性,以改变途径.
主要成果:
- 在许多恶性瘤中,CK2-HTATSF1-TOPBP1轴过度激活,与乳腺瘤中化疗反应减少有关.
- 这个轴上的删除突变预测了更高的HR缺陷.
- 在HTATSF1中的功能丧失突变使瘤细胞对PARP抑制剂和药物敏感.
结论:
- CK2-HTATSF1-TOPBP1轴的完整性与癌症的发展有关.
- 这条途径作为瘤HR状态的生物标志物,并影响化疗结果.
相关概念视频
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Treatment Resistant Cancers


